A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Gastric bypass has profound effects on glycemic control in adults with type 2 diabetes mellitus. The goal of this study was to examine the long-term rates and clinical predictors of diabetes remission and relapse among patients undergoing gastric bypass.
We conducted a retrospective cohort study of adults with uncontrolled or medication-controlled type 2 diabetes who underwent gastric bypass from 1995 to 2008 in three integrated health care delivery systems in the USA. Remission and relapse events were defined by diabetes medication use and clinical laboratory measures of glycemic control. We identified 4,434 adults with uncontrolled or medication-controlled type 2 diabetes who had gastric bypass.
Overall, 68.2 % (95 % confidence interval [CI], 66 and 70 %) experienced an initial complete diabetes remission within 5 years after surgery. Among these, 35.1 % (95 % CI, 32 and 38 %) redeveloped diabetes within 5 years. The median duration of remission was 8.3 years. Significant predictors of complete remission and relapse were poor preoperative glycemic control, insulin use, and longer diabetes duration. Weight trajectories after surgery were significantly different for never remitters, relapsers, and durable remitters (p = 0.03).
Gastric bypass surgery is associated with durable remission of type 2 diabetes in many but not all severely obese diabetic adults, and about one third experience a relapse within 5 years of initial remission. More research is needed to understand the mechanisms of diabetes relapse, the optimal timing of surgery in effecting a durable remission, and the relationship between remission duration and incident microvascular and macrovascular events.
- Pories, WJ, Dohm, LG, Mansfield, CJ (2010) Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring) 18: pp. 865-871 CrossRef
- Buchwald, H, Estok, R, Fahrbach, K (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122: pp. 248-256 CrossRef
- Buchwald, H, Avidor, Y, Braunwald, E (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: pp. 1724-1737 CrossRef
- Pories, WJ, MacDonald, KG, Morgan, EJ (1992) Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55: pp. 582S-585S
- Pories, WJ, Swanson, MS, MacDonald, KG (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222: pp. 339-350 CrossRef
- Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012 (in press).
- Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012 (in press).
- Dixon, JB, O’Brien, PE, Playfair, J (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299: pp. 316-323 CrossRef
- Cummings, DE (2012) Metabolic surgery for type 2 diabetes. Nat Med 18: pp. 656-658 CrossRef
- Thaler, JP, Cummings, DE (2009) Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150: pp. 2518-2525 CrossRef
- Rubino, F, Schauer, PR, Kaplan, LM, Cummings, DE (2010) Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annual Rev Med 61: pp. 393-411 CrossRef
- Cummings, DE (2009) Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 33: pp. S33-S40 CrossRef
- Cummings, DE, Overduin, J, Foster-Schubert, KE (2004) Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89: pp. 2608-2615 CrossRef
- Cummings, DE, Shannon, MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?. J Clin Endocrinol Metab 88: pp. 2999-3002 CrossRef
- Phurrough S, Salive ME, Brechner RJ, Meltzer A. Coverage decision memorandum for surgery for diabetes. 2008. Services CfMaM, ed.
- American Diabetes, A, Bantle, JP, Wylie-Rosett, J, American Diabetes, A, Bantle, JP, Wylie-Rosett, J (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31: pp. S61-S78 CrossRef
- Sjostrom, L, Lindroos, AK, Peltonen, M (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: pp. 2683-2693 CrossRef
- Chikunguwo, SM, Wolfe, LG, Dodson, P (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6: pp. 254-259 CrossRef
- DiGiorgi, M, Rosen, DJ, Choi, JJ (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6: pp. 249-253 CrossRef
- Vetter, ML, Cardillo, S, Rickels, MR, Iqbal, N (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150: pp. 94-103
- International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: pp. 1327-1334 CrossRef
- Buse, JB, Caprio, S, Cefalu, WT (2009) How do we define cure of diabetes?. Diabetes Care 32: pp. 2133-2135 CrossRef
- Collett D. Modeling survival data in medical research. 2003; Chapman and Hall/CRC.
- Hastie, TJ Generalized additive models. In: Chambers, JM, Hastie, TJ eds. (1992) Statistical models in S. T Bell Laboratories, Yonkers, pp. 249-308
- Diggle, P, Heagerty, P, Liang, K, Zeger, SL (2002) Analysis of longitudinal data. Oxford University Press, Oxford
- Ness, PH, Allore, HG, Fried, TR, Lin, H (2010) Inverse intensity weighting in generalized linear models as an option for analyzing longitudinal data with triggered observations. Am J Epidemiol 171: pp. 105-112 CrossRef
- Pournaras, DJ, Aasheim, ET, Sovik, TT (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 99: pp. 100-103 CrossRef
- Renard, E (2009) Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes. Diabetes Metab 35: pp. 564-568 CrossRef
- Arterburn D, Schauer DP, Wise RE, et al. Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg 2008.
- Schauer, DP, Arterburn, DE, Livingston, EH, Fischer, D, Eckman, MH (2010) Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity. Arch Surg 145: pp. 57-62 CrossRef
- Karlsson, J, Sjostrom, L, Sullivan, M (1998) Swedish obese subjects (SOS)–an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 22: pp. 113-126 CrossRef
- Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: pp. 2159-2167 CrossRef
- Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. Am J Ophthalmol 2000; 129:704–5.
- Cleary, PA, Orchard, TJ, Genuth, S (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55: pp. 3556-3565 CrossRef
- Holman, RR, Paul, SK, Bethel, MA, Matthews, DR, Neil, HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: pp. 1577-1589 CrossRef
- Murray, P, Chune, GW, Raghavan, VA (2010) Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials. Curr Atheroscler Rep 12: pp. 432-439 CrossRef
- Kadera, BE, Lum, K, Grant, J, Pryor, AD, Portenier, DD, DeMaria, EJ (2009) Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis 5: pp. 305-309 CrossRef
- Nannipieri, M, Mari, A, Anselmino, M (2011) The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 96: pp. E1372-E1379 CrossRef
- Schauer, PR, Burguera, B, Ikramuddin, S (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238: pp. 467-484
- Hamza, N, Abbas, MH, Darwish, A, Shafeek, Z, New, J, Ammori, BJ (2011) Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 7: pp. 691-696 CrossRef
- Campos, GM, Rabl, C, Mulligan, K (2008) Factors associated with weight loss after gastric bypass. Arch Surg 143: pp. 877-883 CrossRef
- Carbonell, AM, Wolfe, LG, Meador, JG, Sugerman, HJ, Kellum, JM, Maher, JW (2008) Does diabetes affect weight loss after gastric bypass?. Surg Obes Relat Dis 4: pp. 441-444 CrossRef
- Melton, GB, Steele, KE, Schweitzer, MA, Lidor, AO, Magnuson, TH (2008) Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 12: pp. 250-255 CrossRef
- A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass
Volume 23, Issue 1 , pp 93-102
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Gastric bypass
- Industry Sectors
- Author Affiliations
- 1. Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA, 98101, USA
- 2. HealthPartners Institute for Education and Research, Minneapolis, MN, USA
- 3. Kaiser Permanente Northern California, Oakland, CA, USA
- 4. Kaiser Permanente Southern California, Pasadena, CA, USA
- 6. Harvard School of Public Health, Boston, MA, USA
- 5. University of Wisconsin, Madison, WI, USA
- 7. Patient Centered Outcomes Research Institute, Washington, DC, USA